{"id":"https://openalex.org/W2332331891","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.3054","title":"A phase I study of BIBF 1120, an orally active triple angiokinase inhibitor (VEGFR, PDGFR, FGFR) in patients with advanced solid malignancies","display_name":"A phase I study of BIBF 1120, an orally active triple angiokinase inhibitor (VEGFR, PDGFR, FGFR) in patients with advanced solid malignancies","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2332331891","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.3054","mag":"2332331891"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.23.16_suppl.3054","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.3054","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.3054","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066194138","display_name":"C. P. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. P. Lee","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000156180","display_name":"Gerhardt Attard","orcid":"https://orcid.org/0000-0002-4811-7983","observed_orcids":["https://orcid.org/0000-0002-4811-7983"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Attard","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048953130","display_name":"L. Poupard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L. Poupard","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085499539","display_name":"Paul Nathan","orcid":"https://orcid.org/0000-0002-2327-3250","observed_orcids":["https://orcid.org/0000-0002-2327-3250","https://orcid.org/0000-0002-5612-8439"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. D. Nathan","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. S. de Bono","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079797788","display_name":"Graham Temple","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. M. R. Temple","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113596295","display_name":"Martin \u0160tefani\u010d","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. F. Stefanic","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043512230","display_name":"Anwar R. Padhani","orcid":"https://orcid.org/0000-0002-5830-5777","observed_orcids":["https://orcid.org/0000-0002-5830-5777"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. R. Padhani","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000658269","display_name":"I. R. Judson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"I. R. Judson","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047753094","display_name":"Gordon J.S. Rustin","orcid":"https://orcid.org/0000-0002-2749-5467","observed_orcids":["https://orcid.org/0000-0002-2749-5467"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. J. Rustin","raw_affiliation_strings":["Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hosp, Sutton, United Kingdom; Mount Vernon Cancer Ctr, Middlesex, United Kingdom; Boehringer Ingelheim Ltd, Berkshire, United Kingdom","institution_ids":["https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210121186"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"16_suppl","first_page":"3054","last_page":"3054"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vegfr-inhibition","display_name":"VEGFR inhibition","score":0.7839999794960022},{"id":"https://openalex.org/keywords/pdgfr-inhibition","display_name":"PDGFR inhibition","score":0.8870000243186951},{"id":"https://openalex.org/keywords/fgfr-inhibition","display_name":"FGFR inhibition","score":0.9929999709129333},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7400000095367432},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8899999856948853},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.7429999709129333},{"id":"https://openalex.org/keywords/dynamic-contrast-enhanced-mri","display_name":"dynamic contrast-enhanced MRI","score":0.8159999847412109},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.7570000290870667},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.5699999928474426},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.656000018119812},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.531000018119812},{"id":"https://openalex.org/keywords/leiomyomatosis","display_name":"leiomyomatosis","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8479027152061462},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.551943302154541},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5411256551742554},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4924095869064331},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.46685320138931274},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.46261316537857056},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.4366361200809479},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.43635228276252747},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.4188210964202881},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41624921560287476},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4159366488456726},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3771572709083557},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3614858388900757},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3555709719657898},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3340259790420532},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3208152651786804},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1414131224155426},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.23.16_suppl.3054","doi":"https://doi.org/10.1200/jco.2005.23.16_suppl.3054","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2005.23.16_suppl.3054","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2282484382","https://openalex.org/W2158366593","https://openalex.org/W2140856191","https://openalex.org/W2246054985","https://openalex.org/W2222954024","https://openalex.org/W2615148567","https://openalex.org/W2148326226","https://openalex.org/W2316935198","https://openalex.org/W2338459590","https://openalex.org/W1974234923"],"abstract_inverted_index":{"3054":[0],"Background:":[1],"BIBF":[2,42,329],"1120":[3,43,330],"is":[4,345],"a":[5,34,45,113,278],"potent":[6],"orally":[7],"available":[8],"inhibitor":[9],"of":[10,21,25,36,62,116,144,222,266],"VEGF,":[11],"PDGF":[12],"and":[13,54,97,185,256,277,296,338],"FGF":[14],"receptor":[15],"kinases.":[16],"It":[17],"also":[18],"inhibits":[19],"members":[20],"the":[22,60,300],"Src":[23],"family":[24],"tyrosine":[26],"kinases":[27],"(Src,":[28],"Lck,":[29],"Lyn).":[30],"Methods:":[31],"Pts":[32,154],"with":[33,112,205,260,280,299,335,347],"variety":[35],"advanced":[37,336],"solid":[38],"malignancies":[39,117],"were":[40,77,90,138,155,175,232,310],"enrolled.":[41,120],"as":[44,203,342],"continuous":[46],"once":[47],"daily":[48,354],"dosing":[49],"was":[50,201,331,340],"started":[51],"at":[52,92,157,198,213,352],"100mg/day":[53],"doubled":[55],"in":[56,189,194,291,333],"successive":[57],"cohorts":[58],"until":[59],"observation":[61],"\u2265CTC":[63],"grade":[64],"(gr)":[65],"2":[66,146,206,220,272],"drug-related":[67],"toxicities.":[68],"Thereafter,":[69],"escalation":[70],"steps":[71],"by":[72],"no":[73],"more":[74],"than":[75],"50%":[76],"allowed.":[78],"All":[79],"pts":[80,110,132,207,226,237,322,334,349],"underwent":[81,323],"pharmacokinetic":[82],"(PK)":[83],"sampling.":[84],"Dynamic":[85],"contrast-enhanced":[86],"MRI":[87],"(DCE-MRI)":[88],"studies":[89,325],"performed":[91],"baseline,":[93],"days":[94,136,150],"2,":[95],"28":[96,321],"56":[98],"to":[99,217,274,304],"assess":[100],"functional":[101],"tumour":[102],"change":[103],"following":[104],"treatment.":[105,224],"Results:":[106],"To":[107],"date,":[108],"39":[109],"(18M/21F)":[111],"wide":[114],"range":[115],"have":[118],"been":[119],"Median":[121,142],"age:":[122],"57":[123],"yrs":[124],"(range:":[125,148],"22\u201377).":[126],"ECOG":[127],"PS":[128],"0/1:":[129],"17/22.":[130],"37":[131],"who":[133,227],"had":[134,228,238,263,283],"\u226521":[135],"treatment":[137,231],"evaluable":[139],"for":[140,234,240,285],"toxicity.":[141],"duration":[143],"treatment:":[145],"months":[147,247,273],"8":[149],"-":[151],"13":[152],"months).":[153],"treated":[156,351],"5":[158],"dose":[159],"levels:":[160],"100mg/d":[161],"(n=6),":[162,164,166],"200mg/d":[163],"300mg/d":[165],"400mg/d":[167,339],"(n=14),":[168],"450mg/d":[169,214],"(n=5).":[170],"The":[171],"most":[172],"common":[173],"toxicities":[174],"nausea,":[176],"vomiting,":[177],"diarrhoea,":[178],"abdominal":[179],"pain,":[180],"fatigue":[181],"(all":[182],"\u2264gr":[183],"2)":[184],"asymptomatic,":[186],"reversible":[187],"elevation":[188,212],"liver":[190,210],"enzymes":[191],"(gr":[192],"3":[193],"10":[195,236,275],"pts)":[196],"seen":[197],"\u2265200mg/d.":[199],"MTD":[200],"identified":[202],"400mg/d,":[204],"experiencing":[208],"dose-limiting":[209],"enzyme":[211],"which":[215],"returned":[216],"baseline":[218],"within":[219],"weeks":[221],"stopping":[223],"29":[225],"\u22658":[229],"weeks\u2019":[230],"assessable":[233],"response:":[235],"SD":[239,284],"4,":[241],"5,":[242],"6,":[243],"7,":[244],"8.5,":[245],"11":[246,286],"(ovarian,":[248],"cervical,":[249],"colon,":[250],"prostate,":[251],"renal":[252,281],"cancer,":[253],"GIST,":[254],"NSCLC":[255],"leiomyomatosis).":[257],"One":[258],"pt":[259,279],"prostate":[261],"cancer":[262,282],"significant":[264],"prolongation":[265],"his":[267],"PSA":[268],"doubling":[269],"time":[270],"from":[271,318],"months,":[276],"months.":[287],"PK":[288],"analysis":[289],"showed":[290],"general":[292],"increasing":[293],"mean":[294],"Cmax":[295,308],"AUC":[297],"values":[298,309],"dose,":[301],"displaying":[302],"moderate":[303],"high":[305],"interpatient":[306],"variability.":[307],"reached":[311],"\u223c3":[312],"hrs":[313],"after":[314],"dosing.":[315,355],"Mean":[316],"t1/2ranged":[317],"7.5\u201314.0":[319],"hrs.":[320],"DCE-MRI":[324],"(analysis":[326],"on-going).":[327],"Conclusions:":[328],"well-tolerated":[332],"malignancy":[337],"defined":[341],"MTD.":[343],"Study":[344],"on-going":[346],"further":[348],"being":[350],"twice":[353],"Author":[356],"Disclosure":[357],"Employment":[358],"or":[359,362],"Leadership":[360],"Consultant":[361],"Advisory":[363],"Role":[364],"Stock":[365],"Ownership":[366],"Honoraria":[367],"Research":[368],"Funding":[369],"Expert":[370],"Testimony":[371],"Other":[372],"Remuneration":[373],"Boehringer":[374,378],"Ingelheim":[375],"Ltd.":[376],"AstraZeneca,":[377],"Ingelheim,":[379],"Celgene,":[380],"Novartis,":[381],"Topotargets":[382],"Chroma,":[383],"GlaxoSmithKline,":[384],"Oncolytics":[385],"Biotech,":[386],"Roche":[387],"Chiron,":[388],"Human":[389],"Genome":[390],"Sciences,":[391],"Pfizer":[392]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}